Black Diamond Therapeutics, Inc.

NASDAQ:BDTX

Biotechnology

Healthcare
$1.43 -2.40%

-$0.04 today

Market cap
$82.18M
Beta
3.23
P/E (TTM)
-2.2
EPS (TTM)
-$0.75
52W Low $1.62High $4.94

Volume 0.60M

Average 1.31M

Balance Sheet

Inspect the capital base behind the business.

Assets

$143.01M

FY 2025 · Annual

+16.6% YoY

Liabilities

$30.80M

FY 2025 · Annual

-21.7% YoY

Equity

$112.21M

FY 2025 · Annual

+34.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents65.8M34.32M56.22M36.44M20.99M
Short-term Investments143.99M88.49M75.18M62.14M107.66M
Net Receivables00000
Inventory00000
Other Current Assets04.9M2.63M2.6M3.79M
Total Current Assets215.7M127.71M134.03M101.18M132.44M
Property, Plant & Equipment (Net)30.74M27.38M23.71M20.4M9.67M
Goodwill00000
Intangible Assets00000
Long-term Investments0000829K
Tax Assets00000
Other Non-current Assets1.24M1.17M823K1.07M73K
Total Non-current Assets31.98M28.55M24.53M21.46M10.57M
Total Assets247.68M156.26M158.57M122.64M143.01M
Account Payables4.11M1.88M2.32M4.01M579K
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities00000
Total Current Liabilities23.64M15.26M19.65M20.57M15.73M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities28.14M25.3M22.19M18.78M15.07M
Total Liabilities51.78M40.56M41.83M39.36M30.8M
Common Stock5K5K7K7K8K
Retained Earnings(243.82M)(334.99M)(417.43M)(487.11M)(464.74M)
Accumulated OCI(414K)(1.82M)(27K)24K101K
Other Stockholders Equity00000
Minority Interest00000
Total Equity195.9M115.7M116.74M83.29M112.21M
Total Debt28.46M28.14M25.3M22.19M18.78M
Net Debt(37.34M)(6.18M)(30.92M)(14.25M)(2.21M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$30.1M
Short-term Investments$88.2M
Other Current$4.7M
Total Current Assets$123.0M
PP&E (Net)$9.1M
Long-term Investments$831.0K
Other Non-current$29.0K
Total Non-current Assets$10.0M
Total Assets$132.9M

Analysis

Selected assets total $132.9M for Latest. The largest visible component is Short-term Investments at $88.2M, about 66.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipSep 21, 2026
4Statement of changes in beneficial ownershipSep 21, 2026
8-KCurrent reportAug 5, 2026

How much cash does BDTX have?

Black Diamond Therapeutics, Inc. (BDTX) reported $20.99M in cash and equivalents in fiscal 2025.

How much debt does BDTX carry?

Black Diamond Therapeutics, Inc. (BDTX) reported $18.78M of total debt, with net debt of -$2.21M.